欧洲大型神经血管中心过去十年颅内动脉瘤治疗方式的变化
该回顾性观察研究纳入赫尔辛基大学医院2012—2022年连续治疗的2491例颅内动脉瘤患者(44%破裂,56%未破裂),其中1421例(57%)接受手术治疗、1070例(43%)接受血管内治疗。手术比例从2012年的90%降至2022年的20%,除大脑中动脉动脉瘤外各部位均显著向血管内治疗转变。
要点
- 2012—2022年连续治疗的2491例颅内动脉瘤中,57%手术、43%血管内治疗。
- 手术占比从2012年90%降至2022年20%,年龄校正后所有动脉瘤每年下降6.9%。
- 大脑中动脉动脉瘤治疗方式无变化,2022年仍有85%接受手术治疗。
核心结论
- 除大脑中动脉动脉瘤外,所有部位动脉瘤的治疗方式均从手术显著转向血管内治疗。
- 这一转变是否影响长期安全性和患者结局,应在未来进行评估。
研究设计与样本
- 回顾性观察研究,连续纳入赫尔辛基大学医院2012—2022年治疗的未破裂或破裂颅内动脉瘤患者。
- 共2491例患者,其中44%为破裂动脉瘤、56%为未破裂动脉瘤;1421例(57%)接受手术治疗,1070例(43%)接受血管内治疗。
- 采用泊松回归分析报告按动脉瘤部位和破裂状态分层的年龄校正治疗趋势。
主要发现
- 总体趋势为接受治疗的动脉瘤数量减少。
- 手术治疗患者比例从2012年的90%降至2022年的20%。
- 年龄校正后手术相对于血管内治疗的下降幅度:所有动脉瘤为每年6.9%,破裂动脉瘤为每年6.8%,未破裂动脉瘤为每年6.8%。
- 手术治疗下降最明显者:未破裂椎基底动脉瘤每年10.8%,未破裂交通动脉瘤每年10.1%,破裂交通动脉瘤每年10.0%,破裂颈内动脉瘤每年9.0%。
- 大脑中动脉动脉瘤治疗方式无变化,2022年仍有85%接受手术治疗;接受治疗的破裂动脉瘤尺寸呈增大趋势(p=0.033)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment modality for ruptured and unruptured intracranial aneurysms has shifted during the last two decades from microsurgical treatment towards endovascular treatment. We present how this transition happened in a large European neurovascular center. METHODS: We conducted a retrospective observational study consecutive patients treated for an unruptured or ruptured intracranial aneurysm at Helsinki University Hospital during 2012-2022. We used Poisson regression analysis to report age-adjusted treatment trends by aneurysm location and rupture status. RESULTS: A total of 2491 patients with intracranial aneurysms were treated (44% ruptured, 56% unruptured): 1421 (57%) surgically and 1070 (43%) endovascularly. A general trend towards fewer treated aneurysms was noted. The proportion of patients treated surgically decreased from 90% in 2012 to 20% in 2022. The age-adjusted decrease of surgical versus endovascular treatment was 6.9%/year for all aneurysms, 6.8% for ruptured aneurysms, and 6.8% for unruptured aneurysms. The decrease of surgical treatment was most evident in unruptured vertebrobasilar aneurysms (10.8%/year), unruptured communicating artery aneurysms (10.1%/year), ruptured communicating artery aneurysms (10.0%/year), and ruptured internal carotid aneurysms (9.0%/year). There was no change in treatment modality for middle cerebral artery aneurysms, of which 85% were still surgically treated in 2022. A trend towards an increasing size for treated ruptured aneurysms was found (p = 0.033). CONCLUSION: A significant shift of the treatment modality from surgical to endovascular treatment occurred for all aneurysm locations except for middle cerebral artery aneurysms. Whether this shift has affected long-term safety and patient outcomes should be assessed in the future.
引用
- Calvanese F, Auricchio AM, Pohjola A, et al. Changes in treatment of intracranial aneurysms during the last decade in a large European neurovascular center. Acta Neurochir (Wien). 2024. PMID: 38594469. doi:10.1007/s00701-024-06064-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。